Literature DB >> 32870297

Association of New-Onset Atrial Fibrillation After Noncardiac Surgery With Subsequent Stroke and Transient Ischemic Attack.

Konstantinos C Siontis1, Bernard J Gersh1, Susan A Weston2, Ruoxiang Jiang2, Anthony H Kashou3, Véronique L Roger1,2, Peter A Noseworthy1,4, Alanna M Chamberlain2.   

Abstract

Importance: Outcomes of postoperative atrial fibrillation (AF) after noncardiac surgery are not well defined. Objective: To determine the association of new-onset postoperative AF vs no AF after noncardiac surgery with risk of nonfatal and fatal outcomes. Design, Setting, and Participants: Retrospective cohort study in Olmsted County, Minnesota, involving 550 patients who had their first-ever documented AF within 30 days after undergoing a noncardiac surgery (postoperative AF) between 2000 and 2013. Of these patients, 452 were matched 1:1 on age, sex, year of surgery, and type of surgery to patients with noncardiac surgery who were not diagnosed with AF within 30 days following the surgery (no AF). The last date of follow-up was December 31, 2018. Exposures: Postoperative AF vs no AF after noncardiac surgery. Main Outcomes and Measures: The primary outcome was ischemic stroke or transient ischemic attack (TIA). Secondary outcomes included subsequent documented AF, all-cause mortality, and cardiovascular mortality.
Results: The median age of the 452 matched patients was 75 years (IQR, 67-82 years) and 51.8% of patients were men. Patients with postoperative AF had significantly higher CHA2DS2-VASc scores than those in the no AF group (median, 4 [IQR, 2-5] vs 3 [IQR, 2-5]; P < .001). Over a median follow-up of 5.4 years (IQR, 1.4-9.2 years), there were 71 ischemic strokes or TIAs, 266 subsequent documented AF episodes, and 571 deaths, of which 172 were cardiovascular related. Patients with postoperative AF exhibited a statistically significantly higher risk of ischemic stroke or TIA (incidence rate, 18.9 vs 10.0 per 1000 person-years; absolute risk difference [RD] at 5 years, 4.7%; 95% CI, 1.0%-8.4%; HR, 2.69; 95% CI, 1.35-5.37) compared with those with no AF. Patients with postoperative AF had statistically significantly higher risks of subsequent documented AF (incidence rate 136.4 vs 21.6 per 1000 person-years; absolute RD at 5 years, 39.3%; 95% CI, 33.6%-45.0%; HR, 7.94; 95% CI, 4.85-12.98), and all-cause death (incidence rate, 133.2 vs 86.8 per 1000 person-years; absolute RD at 5 years, 9.4%; 95% CI, 4.9%-13.7%; HR, 1.66; 95% CI, 1.32-2.09). No significant difference in the risk of cardiovascular death was observed for patients with and without postoperative AF (incidence rate, 42.5 vs 25.0 per 1000 person-years; absolute RD at 5 years, 6.2%; 95% CI, 2.2%-10.4%; HR, 1.51; 95% CI, 0.97-2.34). Conclusions and Relevance: Among patients undergoing noncardiac surgery, new-onset postoperative AF compared with no AF was associated with a significant increased risk of stroke or TIA. However, the implications of these findings for the management of postoperative AF, such as the need for anticoagulation therapy, require investigation in randomized trials.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32870297      PMCID: PMC7489856          DOI: 10.1001/jama.2020.12518

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  20 in total

1.  Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery.

Authors:  David Conen; Pablo Alonso-Coello; James Douketis; Matthew T V Chan; Andrea Kurz; Alben Sigamani; Joel L Parlow; Chew Yin Wang; Juan C Villar; Sadeesh K Srinathan; Maria Tiboni; German Malaga; Gordon Guyatt; Soori Sivakumaran; Maria-Virginia Rodriguez Funes; Patricia Cruz; Homer Yang; George K Dresser; Jesus Alvarez-Garcia; Thomas Schricker; Philip M Jones; Leanne W Drummond; Kumar Balasubramanian; Salim Yusuf; P J Devereaux
Journal:  Eur Heart J       Date:  2020-02-01       Impact factor: 29.983

2.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

3.  Perioperative atrial fibrillation and the long-term risk of ischemic stroke.

Authors:  Gino Gialdini; Katherine Nearing; Prashant D Bhave; Ubaldo Bonuccelli; Costantino Iadecola; Jeff S Healey; Hooman Kamel
Journal:  JAMA       Date:  2014-08-13       Impact factor: 56.272

4.  A community-based study of stroke incidence after myocardial infarction.

Authors:  Brandi J Witt; Robert D Brown; Steven J Jacobsen; Susan A Weston; Barbara P Yawn; Véronique L Roger
Journal:  Ann Intern Med       Date:  2005-12-06       Impact factor: 25.391

5.  Incidence and Prognostic Impact of Atrial Fibrillation After Discharge Following Revascularization for Significant Left Main Coronary Artery Narrowing.

Authors:  Ioanna Kosmidou; Yangbo Liu; Zixuan Zhang; Björn Redfors; Arie Pieter Kappetein; Patrick W Serruys; Bernard J Gersh; David E Kandzari; Marie-Claude Morice; Paweł E Buszman; Andrzej Bochenek; Erick Schampaert; Joseph F Sabik; Ori Ben-Yehuda; Gregg W Stone
Journal:  Am J Cardiol       Date:  2019-11-19       Impact factor: 2.778

6.  Implications of new-onset atrial fibrillation after cardiac surgery on long-term prognosis: a community-based study.

Authors:  Rowlens M Melduni; Hartzell V Schaff; Kent R Bailey; Stephen S Cha; Naser M Ammash; James B Seward; Bernard J Gersh
Journal:  Am Heart J       Date:  2015-06-28       Impact factor: 4.749

7.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Authors:  Gregory Y H Lip; Robby Nieuwlaat; Ron Pisters; Deirdre A Lane; Harry J G M Crijns
Journal:  Chest       Date:  2009-09-17       Impact factor: 9.410

8.  New onset postoperative atrial fibrillation is associated with a long-term risk for stroke and death following cardiac surgery.

Authors:  Peter Horwich; Karen J Buth; Jean-Francois Légaré
Journal:  J Card Surg       Date:  2012-11-27       Impact factor: 1.620

Review 9.  History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population.

Authors:  Walter A Rocca; Barbara P Yawn; Jennifer L St Sauver; Brandon R Grossardt; L Joseph Melton
Journal:  Mayo Clin Proc       Date:  2012-11-28       Impact factor: 7.616

10.  No Decline in the Risk of Stroke Following Incident Atrial Fibrillation Since 2000 in the Community: A Concerning Trend.

Authors:  Alanna M Chamberlain; Robert D Brown; Alvaro Alonso; Bernard J Gersh; Jill M Killian; Susan A Weston; Véronique L Roger
Journal:  J Am Heart Assoc       Date:  2016-06-13       Impact factor: 5.501

View more
  4 in total

1.  Amiodarone with or without N-Acetylcysteine for the Prevention of Atrial Fibrillation after Thoracic Surgery: A Double-blind, Randomized Trial.

Authors:  David Amar; Hao Zhang; Mina K Chung; Kay See Tan; Dawn Desiderio; Bernard J Park; Alessia Pedoto; Nancy Roistacher; James M Isbell; Daniela Molena; Ginger L Milne; Bryan F Meyers; Gregory W Fischer; Valerie W Rusch; David R Jones
Journal:  Anesthesiology       Date:  2022-06-01       Impact factor: 7.892

2.  Associations of Atrial Fibrillation After Noncardiac Surgery With Stroke, Subsequent Arrhythmia, and Death : A Cohort Study.

Authors:  Konstantinos C Siontis; Bernard J Gersh; Susan A Weston; Ruoxiang Jiang; Véronique L Roger; Peter A Noseworthy; Alanna M Chamberlain
Journal:  Ann Intern Med       Date:  2022-07-26       Impact factor: 51.598

3.  Use of Artificial Intelligence Tools Across Different Clinical Settings: A Cautionary Tale.

Authors:  Konstantinos C Siontis; Peter A Noseworthy; Arman Arghami; Susan A Weston; Zachi I Attia; Juan A Crestanello; Paul A Friedman; Alanna M Chamberlain; Bernard J Gersh
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2021-08-16

4.  Oral anticoagulant use in patients with atrial fibrillation and mitral valve repair.

Authors:  Ashwin S Nathan; Lin Yang; Zhi Geng; Elias J Dayoub; Sameed Ahmed M Khatana; Paul N Fiorilli; Howard C Herrmann; Wilson Y Szeto; Pavan Atluri; Michael A Acker; Nimesh D Desai; David S Frankel; Francis E Marchlinski; Alexander C Fanaroff; Jay Giri; Peter W Groeneveld
Journal:  Am Heart J       Date:  2020-10-24       Impact factor: 5.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.